about
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseMagnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers.Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveThe potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsThe potential of magneto-electric nanocarriers for drug deliveryDevelopment of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesSustained-release nanoART formulation for the treatment of neuroAIDSEffect of human immunodeficiency virus on blood-brain barrier integrity and function: an update.Coupling of transient near infrared photonic with magnetic nanoparticle for potential dissipation-free biomedical application in brainTherapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.Investigational reverse transcriptase inhibitors for the treatment of HIV.Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) EnzymesNanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.Targeted drug delivery to the brain using magnetic nanoparticles.Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders.Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Nano-ART and NeuroAIDS.Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.In Vitro Permeation of FITC-loaded Ferritins Across a Rat Blood-brain Barrier: a Model to Study the Delivery of Nanoformulated Molecules.Aptamers in HIV research diagnosis and therapy.
P2860
Q26746336-159F179E-12A9-4A1C-82FA-694B9A766950Q27317660-319EAD1F-1591-4D64-9BDF-36FB647A89F7Q28075999-CABC3AF0-F34A-40D8-847F-D82AECBD72D5Q28087336-EC72691C-4397-4353-BBC1-DD0C73256463Q30403718-F2C25529-4556-4D3C-B7FF-E1B0C7ADAE1FQ34797004-D63D952F-381A-4BD5-85C1-3FE7D433E199Q35082009-1C198B21-7988-48D0-B227-C6BE3225D1E6Q35708840-3CE3575A-69C2-44A4-8E7F-23B8445E8180Q36087856-BBBE9322-808F-4854-8B52-AE4DDA561975Q36218958-16296788-72EC-4F07-91A7-0A3633515DE5Q36306231-A73E9F32-6A2A-42DB-9947-CAB6C0BADEDEQ36338109-983D386A-23F0-4133-8430-1555C67D071DQ37013364-E98A921B-7269-45DA-B11A-8F9D3C11F3BBQ38601774-DFA317E4-955B-4C21-B3D3-1C22E59D845FQ38748343-09B3D097-8F35-46A1-B9C9-34AB4ECB7413Q38761022-B3173B74-E410-47A6-B33D-4DDFFAA34146Q38823456-BD67082C-AE31-462C-A946-D2950071BCE4Q38856263-0EEF1684-EBCE-436C-9CA0-2E327A184219Q39004638-6A8BE188-D7C0-41EF-848E-AC13EFF574DEQ40060003-A801F651-E8D9-496A-AC1C-BCCCA632477AQ40089319-15F1D0DC-3D8B-4413-B326-0F0F22E8DECCQ48537583-5B0C0DEC-878A-4527-8D6C-E8B5FA9A4E72Q50066811-B01B8999-FEDE-4219-83B7-C8C4459371E5
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Towards nanomedicines for neuroAIDS.
@ast
Towards nanomedicines for neuroAIDS.
@en
Towards nanomedicines for neuroAIDS.
@nl
type
label
Towards nanomedicines for neuroAIDS.
@ast
Towards nanomedicines for neuroAIDS.
@en
Towards nanomedicines for neuroAIDS.
@nl
prefLabel
Towards nanomedicines for neuroAIDS.
@ast
Towards nanomedicines for neuroAIDS.
@en
Towards nanomedicines for neuroAIDS.
@nl
P2093
P2860
P356
P1476
Towards nanomedicines for neuroAIDS.
@en
P2093
Madhavan Nair
Ravi Pottathil
Sudheesh Pilakka-Kanthikeel
Vidya Sagar
P2860
P304
P356
10.1002/RMV.1778
P577
2014-01-07T00:00:00Z